윤소영
#위암#유방암#췌장암#항암치료#담도암#간암#난소암#자궁암
|
학력
고려대학교 의과대학원 졸업 (의학박사)
고려대학교 의과대학원 졸업 (의학석사)
고려대학교 의과대학 졸업 (의학사)
고려대학교 의과대학원 졸업 (의학석사)
고려대학교 의과대학 졸업 (의학사)
경력
Cancer Center at University of California San Diego
고려대학교병원 혈액종양내과 전임의
고려대학교병원 내과 레지던트
고려대학교병원 인턴
고려대학교병원 혈액종양내과 전임의
고려대학교병원 내과 레지던트
고려대학교병원 인턴
논문
Lee KA, Kim HR, Yoon SY. Rheumatic complications in cancer patients treated with immune checkpoint inhibitors. Korean Journal of Internal Medicine. 2019 Nov;34(6):1197-1209.
Kim ST, Kang JH, Lee J, Lee HW, Oh SY, Jang JS, Lee MA, Sohn BS, Yoon SY, Choi HJ, Hong JH, Kim MJ, Kim S, Park YS, Park JO, Lim HY. Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Randomized, Phase Three, Non-Inferiority Trial. Annals of Oncology. 2019 May;30(5):788-795.
Yoon SY. Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients. Supportive Care in Cancer. 2017 Dec;25(12):3759-67.
Yoon SY. An Open-label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer. Cancer Research and Treatment. 2017 Jul;49(3):569-77.
Yoon SY, Ki HK, Kim SY et al. Pneumocystis carinii pneumonia in gastric cancer patients without acquired immune deficiency syndrome: 3 cases report and literature review. J Korean Surg Soc. 2012; 83: 50-55.
Lee MH, Park E, Lee J et al. Cutoff values of serum ferritin and TIBC saturation for the evaluation of gastrointestinal neoplasms in adult anemic patients. Int J Hematol. 2012; 96: 214-221.
Cho YH, Kim SY, Hong Lee M et al. Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer. Gastric Cancer. 2012.
Park SW, Ko SY, Yoon SY et al. Transcatheter arterial embolization for hemoperitoneum: unusual manifestation of iatrogenic injury to abdominal muscular arteries. Abdom Imaging. 2011; 36: 74-78.
Hong MJ, Lee HG, Hur M et al. Slow, but complete, resolution of mitomycin-induced refractory thrombotic thrombocytopenic purpura after rituximab treatment. Korean J Hematol. Korean J Hematol 2011; 46: 45-48.
Lee SY, Song EY, Yun YM et al. Serum prohepcidin levels in Helicobacter pylori infected patients with iron deficiency anemia. Korean J Intern Med. 2010; 25: 195-200.
Kim HR, Kim KW, Yoon SY et al. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis. J Korean Med Sci. 2010; 25: 348-352.
Chung HW, Lee EJ, Cho YH et al. High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma. J Cancer Res Clin Oncol. 2010; 136: 1929-1935.
Yoon SY, Kim SY, Cho YH et al. Hepatic metastases of gastric adenocarcinoma showing metabolic remission on FDG-PET despite an increase in size on CT. Cancer Res Treat. 2009; 41: 100-103.
Joung YH, Lim EJ, Kim MS et al. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B. Int J Oncol. 2008; 33: 477-484.
Yoon SY, Sung HJ, Park KH et al. Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity. Acta Haematol. 2007; 118: 30-37.
Yoon SY, Lee YJ, Seo JH et al. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line. Cell Res. 2006; 16: 75-81.
Kim SJ, Seo HY, Choi JG et al. Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma. Cancer Chemother Pharmacol. 2006; 57: 436-442.
Oh SC, Park KH, Choi IK et al. Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer. Br J Cancer. 2005; 92: 827-831.
Kim SJ, Choi IK, Park KH et al. Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: correlations with clinical parameters and survival. Jpn J Clin Oncol. 2004; 34: 184-190.
Choi IK, Kim BS, Lee KA et al. Efficacy of imatinib mesylate (STI571) in chronic neutrophilic leukemia with t(15;19): case report. Am J Hematol. 2004; 77: 366-369..
Choi CW, Lee J, Park KH et al. Prevalence and characteristics of anemia in the elderly: cross-sectional study of three urban Korean population samples. Am J Hematol. 2004; 77: 26-30.
Choi CW, Sung HJ, Park KH et al. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia. Am J Hematol. 2003; 73: 263-266.
Jeen YT, Yoon SY, Shin SW et al. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma. Cancer. 2001; 91: 2288-2293.
Kim ST, Kang JH, Lee J, Lee HW, Oh SY, Jang JS, Lee MA, Sohn BS, Yoon SY, Choi HJ, Hong JH, Kim MJ, Kim S, Park YS, Park JO, Lim HY. Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Randomized, Phase Three, Non-Inferiority Trial. Annals of Oncology. 2019 May;30(5):788-795.
Yoon SY. Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients. Supportive Care in Cancer. 2017 Dec;25(12):3759-67.
Yoon SY. An Open-label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer. Cancer Research and Treatment. 2017 Jul;49(3):569-77.
Yoon SY, Ki HK, Kim SY et al. Pneumocystis carinii pneumonia in gastric cancer patients without acquired immune deficiency syndrome: 3 cases report and literature review. J Korean Surg Soc. 2012; 83: 50-55.
Lee MH, Park E, Lee J et al. Cutoff values of serum ferritin and TIBC saturation for the evaluation of gastrointestinal neoplasms in adult anemic patients. Int J Hematol. 2012; 96: 214-221.
Cho YH, Kim SY, Hong Lee M et al. Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer. Gastric Cancer. 2012.
Park SW, Ko SY, Yoon SY et al. Transcatheter arterial embolization for hemoperitoneum: unusual manifestation of iatrogenic injury to abdominal muscular arteries. Abdom Imaging. 2011; 36: 74-78.
Hong MJ, Lee HG, Hur M et al. Slow, but complete, resolution of mitomycin-induced refractory thrombotic thrombocytopenic purpura after rituximab treatment. Korean J Hematol. Korean J Hematol 2011; 46: 45-48.
Lee SY, Song EY, Yun YM et al. Serum prohepcidin levels in Helicobacter pylori infected patients with iron deficiency anemia. Korean J Intern Med. 2010; 25: 195-200.
Kim HR, Kim KW, Yoon SY et al. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis. J Korean Med Sci. 2010; 25: 348-352.
Chung HW, Lee EJ, Cho YH et al. High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma. J Cancer Res Clin Oncol. 2010; 136: 1929-1935.
Yoon SY, Kim SY, Cho YH et al. Hepatic metastases of gastric adenocarcinoma showing metabolic remission on FDG-PET despite an increase in size on CT. Cancer Res Treat. 2009; 41: 100-103.
Joung YH, Lim EJ, Kim MS et al. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B. Int J Oncol. 2008; 33: 477-484.
Yoon SY, Sung HJ, Park KH et al. Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity. Acta Haematol. 2007; 118: 30-37.
Yoon SY, Lee YJ, Seo JH et al. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line. Cell Res. 2006; 16: 75-81.
Kim SJ, Seo HY, Choi JG et al. Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma. Cancer Chemother Pharmacol. 2006; 57: 436-442.
Oh SC, Park KH, Choi IK et al. Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer. Br J Cancer. 2005; 92: 827-831.
Kim SJ, Choi IK, Park KH et al. Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: correlations with clinical parameters and survival. Jpn J Clin Oncol. 2004; 34: 184-190.
Choi IK, Kim BS, Lee KA et al. Efficacy of imatinib mesylate (STI571) in chronic neutrophilic leukemia with t(15;19): case report. Am J Hematol. 2004; 77: 366-369..
Choi CW, Lee J, Park KH et al. Prevalence and characteristics of anemia in the elderly: cross-sectional study of three urban Korean population samples. Am J Hematol. 2004; 77: 26-30.
Choi CW, Sung HJ, Park KH et al. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia. Am J Hematol. 2003; 73: 263-266.
Jeen YT, Yoon SY, Shin SW et al. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma. Cancer. 2001; 91: 2288-2293.
저서
저서 내용이 없습니다.
보도자료
[의사가 만난 암환자] 위암4기 불구 늘 밝았던 그녀, 어려운 순간 함께 걸었던 것은 큰 선물
http://news.kmib.co.kr/article/view.asp?arcid=0922991262&code=14130000&cp=nv
[유방암의 모든 것] 유방암의 항암 치료
http://news.kukinews.com/newsView/kuk201310100089
http://news.kmib.co.kr/article/view.asp?arcid=0922991262&code=14130000&cp=nv
[유방암의 모든 것] 유방암의 항암 치료
http://news.kukinews.com/newsView/kuk201310100089
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.